Diagnostic capabilities of magnetic resonance imaging in assessing the myocardial perfusion in cases of ischemic disorders
- Authors: Pogrebnichenko E.R.1, Mameshova A.S.2, Akhmedbekova Z.A.2, Tedurova P.T.2, Kamilov M.A.3, Alibekov E.A.2, Gazimagomedov K.M.2, Saipullaev C.S.2, Popov N.Y.2, Abdulaev A.L.2, Nasueva K.S.4, Bakarova M.M.2, Erkenova Z.V.2
-
Affiliations:
- Children’s city polyclinic No. 1
- Astrakhan State Medical University
- City Polyclinic No. 10
- Kadyrov Chechen State University
- Issue: Vol 16, No 1 (2025)
- Pages: 76-91
- Section: Reviews
- URL: https://journal-vniispk.ru/clinpractice/article/view/295972
- DOI: https://doi.org/10.17816/clinpract648672
- ID: 295972
Cite item
Abstract
Magnetic resonance imaging (MRI) of the heart has proven itself as an important tool for the evaluation of myocardial perfusion and for the diagnostics of myocardial ischemia. Due to its high spatial resolution and absence of X-ray radiation, MRI of the heart allows for precise diagnosing subendocardial ischemia without any adverse effects, which makes it a valuable method for detecting the ischemic heart disease. Recent advances in cardiac MRI and in post-processing have allowed for moving from qualitative to quantitative evaluation of the stress perfusion cardiac MRI, which has significantly increased the objectiveness and the precision of diagnostics. Quantitative evaluation of myocardial perfusion using the MRI provides a possibility of objective evaluation of myocardial ischemia, which can contribute to improved detection of coronary microvascular dysfunctions. The integration of quantitative perfusion MRI with other methods, such as the kinematic MRI, the delayed increase of gadolinium levels and the Т1/Т2-mapping, allows for deeper understanding the pathophysiology and improving the prediction of outcomes for various cardio-vascular diseases. The review addresses modern research works on cardiac MRI with regard to diagnostics and predicting of ischemic heart disease, coronary microvascular dysfunctions or non-ischemic cardiomyopathy, focusing on the quantitative approach in the evaluation of myocardial perfusion and its potential use in clinical practice.
Full Text
##article.viewOnOriginalSite##About the authors
Elina R. Pogrebnichenko
Children’s city polyclinic No. 1
Email: elina.pogrebnichenko@mail.ru
ORCID iD: 0000-0002-4091-1234
pediatrician
Russian Federation, AstrakhanAdelina S. Mameshova
Astrakhan State Medical University
Email: tanatarova.adelina@mail.ru
ORCID iD: 0009-0002-5525-3243
Russian Federation, Astrakhan
Zainab A. Akhmedbekova
Astrakhan State Medical University
Email: akhmedbekova01@mail.ru
ORCID iD: 0009-0009-5231-9578
студент
Russian Federation, AstrakhanPatimat T. Tedurova
Astrakhan State Medical University
Email: Tedurova1@mail.ru
ORCID iD: 0009-0000-0187-6512
Russian Federation, Astrakhan
Mukhammad A. Kamilov
City Polyclinic No. 10
Author for correspondence.
Email: rrstr1990@mail.ru
ORCID iD: 0009-0007-0052-2721
Eldar A. Alibekov
Astrakhan State Medical University
Email: eldaralibekov2002@gmail.com
ORCID iD: 0000-0002-7349-609X
Russian Federation, Astrakhan
Kazimagomed M. Gazimagomedov
Astrakhan State Medical University
Email: gazimagomedov2002@internet.ru
ORCID iD: 0009-0009-1354-3323
Russian Federation, Astrakhan
Chopalav S. Saipullaev
Astrakhan State Medical University
Email: saipullaevch2k19@icloud.com
ORCID iD: 0009-0000-1858-2430
Russian Federation, Astrakhan
Nikolai Yu. Popov
Astrakhan State Medical University
Email: nikolaipopov19-2001@yandex.ru
ORCID iD: 0009-0006-8600-8602
Russian Federation, Astrakhan
Akhmed L. Abdulaev
Astrakhan State Medical University
Email: ahmadent@bk.ru
ORCID iD: 0009-0009-8599-0130
студент
Russian Federation, AstrakhanKhava S. Nasueva
Kadyrov Chechen State University
Email: nasuevakh@gmail.com
ORCID iD: 0009-0000-6021-8755
Russian Federation, Grozny
Madina M. Bakarova
Astrakhan State Medical University
Email: bakarova02@Mail.ru
ORCID iD: 0009-0006-8073-8065
Russian Federation, Astrakhan
Zalina V. Erkenova
Astrakhan State Medical University
Email: Zalinka.erkenova@mail.ru
ORCID iD: 0000-0003-0925-7403
Russian Federation, Astrakhan
References
- Соболева Г.Н., Пивоварова А.И., Стукалова О.В., и др. Возможности качественного и полуколичественного анализа перфузии миокарда по данным стресс-МРТ сердца с аденозинтрифосфатом в диагностике обструктивного атеросклероза коронарных артерий // Кардиоваскулярная терапия и профилактика. 2024. Т. 23, № 7. С. 74–83. [Soboleva GN, Pivovarova AI, Stukalova OV, et al. Potential of qualitative and semi-quantitative analysis of myocardial perfusion according to stress adenosine triphosphate perfusion cardiac MRI in the diagnosis of obstructive coronary artery disease. Cardiovascular therapy and prevention. 2024;23(7):74–83]. doi: 10.15829/1728-8800-2024-4000 EDN: SLOMLJ
- Пивоварова А.И., Соболева Г.Н., Стукалова О.В., и др. Клинический пример использования перфузионной стресс-МРТ сердца с аденозинтрифосфатом у больной сахарным диабетом 2 типа с микрососудистой дисфункцией и обструктивным атеросклерозом коронарных артерий // Кардиологический вестник. 2022;17(4):76-81. [Pivovarova AI, Soboleva GN, Stukalova OV, et al. Perfusion stress cardiac mri with adenosine triphosphate in a patient with type 2 diabetes mellitus, microvascular dysfunction and obstructive atherosclerosis of coronary arteries. Russian cardiology bulletin. 2022;17(4):76–81]. doi: 10.17116/Cardiobulletin20221704176 EDN: VZKEVI
- Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): A prospective trial. Lancet. 2012;379(9814):453–460. doi: 10.1016/S0140-6736(11)61335-4
- Swoboda PP, Matthews GD, Garg P, et al. Comparison of stress-rest and stress-LGE analysis strategy in patients undergoing stress perfusion cardiovascular magnetic resonance. Circ Cardiovasc Imaging. 2023;16(12):e014765. doi: 10.1161/CIRCIMAGING.123.014765 EDN: JIIPHZ
- Arai AE, Schulz-Menger J, Shah DJ, et al. Stress perfusion cardiac magnetic resonance vs SPECT imaging for detection of coronary artery disease. J Am Coll Cardiol. 2023;82(19):1828–1838. doi: 10.1016/j.jacc.2023.08.046 EDN: CWZAYD
- Driessen RS, van Diemen PA, Raijmakers PG, et al. Functional stress imaging to predict abnormal coronary fractional flow reserve: The PACIFIC 2 study. Eur Heart J. 2022;43(33):3118–3128. doi: 10.1093/eurheartj/ehac286 EDN: GZEKPU
- Maddahi J, Agostini D, Bateman TM, et al. Flurpiridaz F-18 PET myocardial perfusion imaging in patients with suspected coronary artery disease. J Am Coll Cardiol. 2023;82(16):1598–1610. doi: 10.1016/j.jacc.2023.08.016 EDN: SBDDCG
- Литвиненко И.В. Возможности ОФЭКТ-КТ в диагностике стенозов коронарных артерий // Медицинская визуализация. 2015. № 2. С. 53–66. [Litvinenko IV. The possibility of SPECT-CT in the diagnosis of coronary artery stenosis. Medical visualization. 2015;(2):53–66]. EDN: TTZQLT
- Takx RA, Blomberg BA, El Aidi H, et al. Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis. Circ Cardiovasc Imaging. 2015;8(1):e002666. doi: 10.1161/CIRCIMAGING.114.002666
- Bashir MR, Bhatti L, Marin D, Nelson RC. Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging. 2015;41(4):884–898. doi: 10.1002/jmri.24691
- Hilbert S, Weber A, Nehrke K, et al. Artefact-free late gadolinium enhancement imaging in patients with implanted cardiac devices using a modified broadband sequence: Current strategies and results from a real-world patient cohort. Europace. 2018;20(5):801–807. doi: 10.1093/europace/eux016
- Мальцева А.Н., Копьева К.В., Мочула А.В., и др. Ассоциация нарушений миокардиального кровотока и резерва с факторами риска сердечно-сосудистых заболеваний у пациентов с необструктивным атеросклеротическим поражением коронарных артерий // Российский кардиологический журнал. 2023. Т. 28, № 2. С. 50–59. [Maltseva AN, Kop’eva KV, Mochula AV, et al. Association of impaired myocardial flow reserve with risk factors for cardiovascular diseases in patients with nonobstructive coronary artery disease. Russian journal of cardiology. 2023;28(2):50–59]. doi: 10.15829/1560-4071-2023-5158 EDN: FNSYNE
- Гуля М.О., Мочула А.В., Мальцева А.Н., Завадовский К.В. Совмещенная перфузионная сцинтиграфия миокарда и компьютерная томография: диагностическая и прогностическая значимость при ишемической болезни сердца // Российский кардиологический журнал. 2022. Т. 27, № 6. С. 108–117. [Gulya MO, Mochula AV, Maltseva AN, Zavadovsky KV. Combined myocardial perfusion scintigraphy and computed tomography: Diagnostic and prognostic value in coronary artery disease. Russian journal of cardiology. 2022;27(6):108–117]. doi: 10.15829/1560-4071-2022-4925 EDN: XRNWVP
- Villa AD, Corsinovi L, Ntalas I, et al. Importance of operator training and rest perfusion on the diagnostic accuracy of stress perfusion cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2018;20(1):74. doi: 10.1186/s12968-018-0493-4 EDN: TPQKWE
- Biglands JD, Ibraheem M, Magee DR, et al. Quantitative myocardial perfusion imaging versus visual analysis in diagnosing myocardial ischemia: A CE-MARC substudy. JACC Cardiovasc Imaging. 2018;11(5):711–718. doi: 10.1016/j.jcmg.2018.02.019
- Crawley R, Kunze KP, Milidonis X, et al. High-resolution free-breathing automated quantitative myocardial perfusion by cardiovascular magnetic resonance for the detection of functionally significant coronary artery disease. Eur Heart J Cardiovasc Imaging. 2024;25(7):914–925. doi: 10.1093/ehjci/jeae084 EDN: XNUMPD
- Patel AR, Antkowiak PF, Nandalur KR, et al. Assessment of advanced coronary artery disease: Advantages of quantitative cardiac magnetic resonance perfusion analysis. J Am Coll Cardiol. 2010;56(7):561–569. doi: 10.1016/j.jacc.2010.02.061
- Ostojic M, Stanetic B. Gold standard for diagnosing and treating chronic ischaemic coronary artery disease and the associated complications. Open Heart. 2024;11(2):e002908. doi: 10.1136/openhrt-2024-002908 EDN: CILUZZ
- Kotecha T, Chacko L, Chehab O, et al. Assessment of multivessel coronary artery disease using cardiovascular magnetic resonance pixelwise quantitative perfusion mapping. JACC Cardiovasc Imaging. 2020;13(12):2546–2557. doi: 10.1016/j.jcmg.2020.06.041 EDN: LAYAHC
- Kwong RY, Ge Y, Steel K, et al. Cardiac magnetic resonance stress perfusion imaging for evaluation of patients with chest pain. J Am Coll Cardiol. 2019;74(14):1741–1755. doi: 10.1016/j.jacc.2019.07.074 EDN: XSLWTI
- Pezel T, Unterseeh T, Kinnel M, et al. Long-term prognostic value of stress perfusion cardiovascular magnetic resonance in patients without known coronary artery disease. J Cardiovasc Magn Reson. 2021;23(1):43. doi: 10.1186/s12968-021-00737-0 EDN: OGSPJD
- Pezel T, Hovasse T, Kinnel M, et al. Long-term prognostic value of stress cardiovascular magnetic resonance in patients with history of percutaneous coronary intervention. Circ Cardiovasc Imaging. 2021;14(6):e012374. doi: 10.1161/CIRCIMAGING.120.012374 EDN: NJHHOO
- Kinnel M, Sanguineti F, Pezel T, et al. Prognostic value of vasodilator stress perfusion CMR in patients with previous coronary artery bypass graft. Eur Heart J Cardiovasc Imaging. 2021;22(11):1264–1272. doi: 10.1093/ehjci/jeaa316 EDN: XIUKIE
- Минасян А.А., Соболева Г.Н., Гаман С.А., и др. Безопасность и эффективность объемной компьютерной томографии сердца в сочетании с фармакологической пробой с аденозинтрифосфатом в диагностике ишемической болезни сердца // Кардиология. 2020. Т. 60, № 11. С. 57–65. [Minasyan AA, Soboleva GN, Gaman SA, et al. Safety and effectiveness of volumetric computed tomography of the heart in combination with a pharmacological test with adenosine triphosphate in the diagnosis of coronary heart disease. Kardiologiia. 2020;60(11):57–65]. doi: 10.18087/cardio.2020.11.n1258 EDN: CUIUUE
- García-Baizán A, Millor M, Bartolomé P, et al. Adenosine triphosphate (ATP) and adenosine cause similar vasodilator effect in patients undergoing stress perfusion cardiac magnetic resonance imaging. Int J Cardiovasc Imaging. 2019;35(4):675–682. doi: 10.1007/s10554-018-1494-y EDN: MKOLJK
- Nakamura S, Ishida M, Nakata K, et al. Complementary prognostic value of stress perfusion imaging and global coronary flow reserve derived from cardiovascular magnetic resonance: A long-term cohort study. J Cardiovasc Magn Reson. 2023;25(1):20. doi: 10.1186/s12968-023-00930-3 EDN: DJGBRU
- Nakamura S, Kitagawa K, Goto Y, et al. Incremental prognostic value of myocardial blood flow quantified with stress dynamic computed tomography perfusion imaging. JACC Cardiovasc Imaging. 2019;12(7 Pt 2):1379–1387. doi: 10.1016/j.jcmg.2018.05.021
- Nakamura S, Kitagawa K, Goto Y, et al. Prognostic value of stress dynamic computed tomography perfusion with computed tomography delayed enhancement. JACC Cardiovasc Imaging. 2020;13(8):1721–1734. doi: 10.1016/j.jcmg.2019.12.017 EDN: FEXATJ
- Ng MY, Chin CY, Yap PM, et al. Prognostic value of perfusion cardiovascular magnetic resonance with adenosine triphosphate stress in stable coronary artery disease. J Cardiovasc Magn Reson. 2021;23(1):75. doi: 10.1186/s12968-021-00770-z
- Kato S, Saito N, Nakachi T, et al. Stress perfusion coronary flow reserve versus cardiac magnetic resonance for known or suspected CAD. J Am Coll Cardiol. 2017;70(7):869–879. doi: 10.1016/j.jacc.2017.06.028
- Indorkar R, Kwong RY, Romano S, et al. Global coronary flow reserve measured during stress cardiac magnetic resonance imaging is an independent predictor of adverse cardiovascular events. JACC Cardiovasc Imaging. 2019;12(8 Pt 2):1686–1695. doi: 10.1016/j.jcmg.2018.08.018
- Cho YK, Nam CW. Would a noninvasive coronary physiology become a standard and popular approach? Korean Circ J. 2021;51(2):140–142. doi: 10.4070/kcj.2020.0511 EDN: RUGVYZ
- Knott KD, Seraphim A, Augusto JB, et al. The prognostic significance of quantitative myocardial perfusion: An artificial intelligence-based approach using perfusion mapping. Circulation. 2020; 141(16):1282–1291. doi: 10.1161/CIRCULATIONAHA.119.044666 EDN: HORRTM
- Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: A report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148(9):е9–е119. doi: 10.1161/CIR.0000000000001168 EDN: UQJEFJ
- Ребров А.П. Коронарная микрососудистая дисфункция при ревматических заболеваниях: что мы знаем сегодня? // Профилактическая медицина. 2024. Т. 27, № 9. С. 138–143. [Rebrov AP. Coronary microvascular dysfunction in rheumatic diseases — what do we know today? Russian journal of preventive medicine. 2024;27(9):138–143]. doi: 10.17116/profmed202427091138 EDN: XZFFRU
- Francia P, Delli Gatti C, Bachschmid M, et al. Deletion of p66shc gene protects against age-related endothelial dysfunction. Circulation. 2004;110(18):2889–2895. doi: 10.1161/01.CIR.0000147731.24444.4D
- Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356(8):830–840. doi: 10.1056/NEJMra061889
- Camici PG, Tschöpe C, Di Carli MF, et al. Coronary microvascular dysfunction in hypertrophy and heart failure. Cardiovasc Res. 2020;116(4):806–816. doi: 10.1093/cvr/cvaa023 EDN: LOQKXK
- Van Heerebeek L, Hamdani N, Handoko ML, et al. Diastolic stiffness of the failing diabetic heart: Importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008;117(1):43–51. doi: 10.1161/CIRCULATIONAHA.107.728550
- Rahman H, Scannell CM, Demir OM, et al. High-resolution cardiac magnetic resonance imaging techniques for the identification of coronary microvascular dysfunction. JACC Cardiovasc Imaging. 2021;14(5):978–986. doi: 10.1016/j.jcmg.2020.10.015 EDN: ALFVKK
- Kotecha T, Martinez-Naharro A, Boldrini M, et al. Automated pixel-wise quantitative myocardial perfusion mapping by CMR to detect obstructive coronary artery disease and coronary microvascular dysfunction: Validation against invasive coronary physiology. JACC Cardiovasc Imaging. 2019;12(10):1958–1969. doi: 10.1016/j.jcmg.2018.12.022
- Wöhrle J, Nusser T, Merkle N, et al. Myocardial perfusion reserve in cardiovascular magnetic resonance: Correlation to coronary microvascular dysfunction. J Cardiovasc Magn Reson. 2006;8(6):781–787. doi: 10.1080/10976640600737649
- Zhou W, Lee JC, Leung ST, et al. Long-term prognosis of patients with coronary microvascular disease using stress perfusion cardiac magnetic resonance. JACC Cardiovasc Imaging. 2021;14(3):602–611. doi: 10.1016/j.jcmg.2020.09.034 EDN: NWYDBC
- Jiang L, Yan WF, Zhang L, et al. Early left ventricular microvascular dysfunction in diabetic pigs: A longitudinal quantitative myocardial perfusion CMR study. Cardiovasc Diabetol. 2024;23(1):9. doi: 10.1186/s12933-023-02106-w EDN: VALAPI
- Yeo JL, Gulsin GS, Brady EM, et al. Association of ambulatory blood pressure with coronary microvascular and cardiac dysfunction in asymptomatic type 2 diabetes. Cardiovasc Diabetol. 2022;21(1):85. doi: 10.1186/s12933-022-01528-2 EDN: LDWEGJ
- Кухаренко С.С., Ядрихинская М.Н., Шацкая О.А., и др. «Изолированная» диастолическая дисфункция миокарда при сахарном диабете: смена представлений // Проблемы эндокринологии. 2016. Т. 62, № 6. С. 10–19. [Kukharenko SS, Yadrikhinskaya MN, Shatskaya OA, et al. Isolated left ventricular diastolic dysfunction in diabetes mellitus: Opinions change. Problems of endocrinology. 2016;62(6):10–19]. doi: 10.14341/probl201662610-19 EDN: XIAIYB
- Bojer AS, Sørensen MH, Madsen SH, et al. The independent association of myocardial extracellular volume and myocardial blood flow with cardiac diastolic function in patients with type 2 diabetes: A prospective cross-sectional cohort study. Cardiovasc Diabetol. 2023;22(1):78. doi: 10.1186/s12933-023-01804-9 EDN: TABMKK
- Шаяхметова С.В., Синицын В.Е., Афанасьев А.В. Магнитно-резонансная томография сердца при гипертрофической кардиомиопатии: диагностические возможности, применение в клинической практике, прогностическая значимость // Российский кардиологический журнал. 2019. Т. 24, № 12. С. 131–136. [Shayakhmetova SV, Sinitsyn VE, Afanasyev AV. Cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: Diagnostic and prognostic value. Russian journal of cardiology. 2019;(12):131–136]. doi: 10.15829/1560-4071-2019-12-131-136 EDN: KEXVJB
- Александрова С.А., Глазкова Е.Ю., Голухова Е.З. Магнитно-резонансная томография сердца при аритмогенной кардиомиопатии: развитие критериев диагностики и новые возможности // Российский кардиологический журнал. 2024. Т. 29, № S11. С. 13–22. [Aleksandrova SA, Glazkova EYu, Golukhova EZ. Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: Evolving diagnostic criteria and new capabilities. Russian journal of cardiology. 2024;29(S11):13–22]. doi: 10.15829/1560-4071-2024-6118 EDN: BYQJOM
- Puntmann VO, Carr-White G, Jabbour A, et al. International T1 multicentre CMR outcome study. T1-mapping and outcome in nonischemic cardiomyopathy: All-cause mortality and heart failure. JACC Cardiovasc Imaging. 2016;9(1):40–50. doi: 10.1016/j.jcmg.2015.12.001
- Ganesan AN, Gunton J, Nucifora G, et al. Impact of late gadolinium enhancement on mortality, sudden death and major adverse cardiovascular events in ischemic and nonischemic cardiomyopathy: A systematic review and meta-analysis. Int J Cardiol. 2018;254:230–237. doi: 10.1016/j.ijcard.2017.10.094
- Cadour F, Quemeneur M, Biere L, et al. Prognostic value of cardiovascular magnetic resonance T1 mapping and extracellular volume fraction in nonischemic dilated cardiomyopathy. J Cardiovasc Magn Reson. 2023;25(1):7. doi: 10.1186/s12968-023-00919-y EDN: CFBPTT
- Hughes RK, Camaioni C, Augusto JB, et al. Myocardial perfusion defects in hypertrophic cardiomyopathy mutation carriers. J Am Heart Assoc. 2021;10(15):e020227. doi: 10.1161/JAHA.120.020227 EDN: JHIMOQ
- Joy G, Kelly CI, Webber M, et al. Microstructural and microvascular phenotype of sarcomere mutation carriers and overt hypertrophic cardiomyopathy. Circulation. 2023;148(10):808–818. doi: 10.1161/CIRCULATIONAHA.123.063835 EDN: DVNBZL
- Raphael CE, Mitchell F, Kanaganayagam GS, et al. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: The role of myocardial replacement fibrosis and the microcirculation. J Cardiovasc Magn Reson. 2021;23(1):26. doi: 10.1186/s12968-021-00720-9 EDN: AZKIBV
- Вайханская Т.Г., Сивицкая Л.Н., Курушко Т.В., и др. Дилатационная кардиомиопатия: новый взгляд на проблему // Российский кардиологический журнал. 2019. Т. 24, № 4. С. 35–47. [Vaykhanskaya TG, Sivitskaya LN, Kurushko TV, et al. Dilated cardiomyopathy: Reconceptualization of the problem. Russian journal of cardiology. 2019;24(4):35–47]. doi: 10.15829/1560-4071-2019-4-35-47 EDN: TQSQAJ
- Van den Heuvel AF, van Veldhuisen DJ, van der Wall EE, et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy: A randomized trial of beta-blockade in heart failure. J Am Coll Cardiol. 2000;35(1):19–28. doi: 10.1016/s0735-1097(99)00499-4 EDN: ADWYUO
- Stolen KQ, Kemppainen J, Kalliokoski KK, et al. Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2004;93(1):64–68. doi: 10.1016/j.amjcard.2003.08.074 EDN: GQQTIJ
- Neglia D, Parodi O, Gallopin M, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation. 1995;92(4):796–804. doi: 10.1161/01.cir.92.4.796
- Roura S, Bayes-Genis A. Vascular dysfunction in idiopathic dilated cardiomyopathy. Nat Rev Cardiol. 2009;6(9):590–598. doi: 10.1038/nrcardio.2009.130
- Gulati A, Ismail TF, Ali A, et al. Microvascular dysfunction in dilated cardiomyopathy: A quantitative stress perfusion cardiovascular magnetic resonance study. JACC Cardiovasc Imaging. 2019;12(8):1699–1708. doi: 10.1016/j.jcmg.2018.10.032
- Takafuji M, Ishida M, Nakamura S, et al. Microvascular dysfunction in patients with idiopathic dilated cardiomyopathy: Quantitative assessment with phase contrast cine mr imaging of the coronary sinus. Magn Reson Med Sci. 2025;24(1):10–19. doi: 10.2463/mrms.mp.2023-0018 EDN: SIDMCH
- Павлюкова Е.Н., Кужель Д.А. Сердечная недостаточность с сохраненной фракцией выброса левого желудочка: роль диастолического стресс-теста в алгоритмах диагностики // Российский кардиологический журнал. 2021. Т. 26, № 2. С. 96–102. [Pavlyukova EN, Kuzhel DA. Heart failure with preserved ejection fraction: The role of diastolic stress test in diagnostic algorithms. Russian journal of cardiology. 2021;26(2):96–102]. doi: 10.15829/1560-4071-2021-4147 EDN: ZJMVXW
- Yang JH, Obokata M, Reddy YN, et al. Endothelium-dependent and independent coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Eur J Heart Fail. 2020;22(3):432–441. doi: 10.1002/ejhf.1671
- Ahmad A, Corban MT, Toya T, et al. Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction. Eur J Heart Fail. 2021;23(5):765–772. doi: 10.1002/ejhf.2010 EDN: VKUBPD
- Shah SJ, Lam CS, Svedlund S, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J. 2018;39(37):3439–3450. doi: 10.1093/eurheartj/ehy531
- Hage C, Svedlund S, Saraste A, et al. Association of coronary microvascular dysfunction with heart failure hospitalizations and mortality in heart failure with preserved ejection fraction: A follow-up in the PROMIS-HFpEF study. J Card Fail. 2020;26(11):1016–1021. doi: 10.1016/j.cardfail.2020.08.010 EDN: PFGNIF
- Arnold JR, Kanagala P, Budgeon CA, et al. Prevalence and prognostic significance of microvascular dysfunction in heart failure with preserved ejection fraction. JACC Cardiovasc Imaging. 2022;15(6):1001–1011. doi: 10.1016/j.jcmg.2021.11.022 EDN: HOAIEN
- Siggins C, Pan JA, Löffler AI, et al. Cardiometabolic biomarker patterns associated with cardiac MRI defined fibrosis and microvascular dysfunction in patients with heart failure with preserved ejection fraction. Front Cardiovasc Med. 2024;11:1334226. doi: 10.3389/fcvm.2024.1334226 EDN: MOXOHQ
- Pons-Lladó G, Kellman P. State-of-the-art of myocardial perfusion by CMR: A practical view. Rev Cardiovasc Med. 2022;23(10):325. doi: 10.31083/j.rcm2310325 EDN: ZYYZNY
Supplementary files
